Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB
Clinical trial NCT03174184 · COMPLETED
Trial details
- NCT number
- NCT03174184
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2022-05-13
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.